Article Abstract

Hidden messages in optical coherence tomography: looking beyond fluid

Authors: Chui Ming Gemmy Cheung, Huan Chen


The outlook for patients with neovascular age-related macular degeneration (AMD) has significantly improved since the advent of anti-vascular endothelial growth factor (anti-VEGF) therapy. Numerous clinical trials have demonstrated favorable visual and anatomical response up to 2 years. However, longer-term results have been variable.